Final concessions list revealed on February 28

The Department of Health and Social Care (DHSC) published the final list of price concessions for February on the last day of the month.

The final list (below), published on February 28 by the PSNC, followed announcements on February 20 and 22.

Alverine 60mg capsules 100 £2.88
Baclofen 10mg tablets 84 £1.97
Celecoxib 100mg capsules 60 £2.40
Chloramphenicol 0.5% eye drops 10ml £2.49
Clomipramine 25mg capsules 28 £4.22
Desogestrel 75microgram tablets 84 £2.60
Diamorphine 10mg powder for solution for injection ampoules 5 £15.87
Diamorphine 30mg powder for solution for injection ampoules 5 £15.57
Irbesartan 75mg tablets 28 £3.10
Irbesartan 300mg tablets 28 £4.84
Losartan 100mg tablets 28 £5.44
Metoprolol 50mg tablets 28 £2.78
Metoprolol 100mg tablets 28 £1.70
Nebivolol 5mg tablets 28 £4.39
Nortriptyline 25mg tablets 100 £9.88
Ondansetron 4mg tablets 10 £7.73
Piroxicam 0.5% gel 112g £3.35
Pramipexole 88microgram tablets 30 £4.58
Quetiapine 25mg tablets 60 £3.48
Quetiapine 300mg tablets 60 £9.51
Ramipril 5mg tablets 28 £3.35
Risperidone 2mg tablets 60 £17.93
Sevelamer 800mg tablets 180 £107.09
Sodium valproate 200mg gastro-resistant tablets 100 £6.99
Sodium valproate 200mg/5ml oral solution sugar free 300ml £7.00
Telmisartan 80mg tablets 28 £8.35
Topiramate 50mg tablets 60 £13.59
Topiramate 100mg tablets 60 £21.07
Valsartan 160mg capsules 28 £9.00


Six claim EPB places amid rumours of unrest

Kidney disease test rolled out to Yorkshire patients

This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Independent Pharmacist's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.